Literature DB >> 27028727

A Comparison Among 5 Methods for the Clinical Diagnosis of Fetal Alcohol Spectrum Disorders.

Claire D Coles1,2, Amanda R Gailey1, Jennifer G Mulle3,4, Julie A Kable1,2, Mary Ellen Lynch1, Kenneth Lyons Jones5.   

Abstract

BACKGROUND: Despite the prevalence of fetal alcohol spectrum disorders (FASD) and the importance of accurate identification of patients, clinical diagnosis may not be consistent across sites due to the heterogeneous nature of FASD and the characteristics of different diagnostic systems used. Here, we compare 5 systems designed to operationalize criteria recommended for the diagnosis of effects of prenatal alcohol exposure (PAE). We determined the extent of consistency among them as well as factors that may reduce intersystem reliability. Compared are: Emory Clinic, Seattle 4-Digit System (Diagnostic Guidelines for Fetal Alcohol Spectrum Disorders: The 4-Digit Diagnostic Code, Seattle, WA, University Publication Services, 2004), Centers for Disease Control and Prevention (Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis, Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2004), Canadian Guidelines (CMAJ, 172, 2005, S1), and the Hoyme Modifications (Pediatrics, 115, 2005, 39).
METHODS: Subjects were 1,581 consecutively registered patients applying for evaluation at a university-based clinic treating alcohol and drug-exposed children. Records of the multidisciplinary evaluation (pediatric, social, psychological) were abstracted. Diagnostic criteria for all 5 systems were applied, and patients were diagnosed according to each of the systems. We compared results using Cohen's Kappa to evaluate the extent of agreement.
RESULTS: Percent of individuals diagnosed with FASD ranged from 4.74% (CDC) to 59.58% (Hoyme). Examination using Cohen's Kappa found modest agreement among systems, particularly when individual diagnoses, Fetal Alcohol Syndrome (FAS), partial FAS (pFAS), and Alcohol-Related Neurodevelopmental Disorder (ARND) were used. Examination of diagnostic criteria found almost perfect agreement on growth (weight; height), with limited overlap for physical features (palpebral fissures, hypoplastic philtrum, upper vermillion) and for neurobehavioral outcomes. Child's race and age influenced agreement among systems, with African American and older children more frequently diagnosed.
CONCLUSIONS: Results suggest problems in convergent validity among these systems, as demonstrated by a lack of reliability in diagnosis. Absence of an external standard makes it impossible to determine whether any system is more accurate, but outcomes do suggest areas for future research that may refine diagnosis.
Copyright © 2016 by the Research Society on Alcoholism.

Entities:  

Keywords:  Diagnoses Phenotype; Fetal Alcohol Spectrum Disorders; Fetal Alcohol Syndrome

Mesh:

Year:  2016        PMID: 27028727      PMCID: PMC6346422          DOI: 10.1111/acer.13032

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  30 in total

Review 1.  Fetal Alcohol Spectrum Disorders: A Review of the Neurobehavioral Deficits Associated With Prenatal Alcohol Exposure.

Authors:  Sarah N Mattson; Gemma A Bernes; Lauren R Doyle
Journal:  Alcohol Clin Exp Res       Date:  2019-05-02       Impact factor: 3.455

2.  Evidence Supporting the Internal Validity of the Proposed ND-PAE Disorder.

Authors:  Julie A Kable; Claire D Coles
Journal:  Child Psychiatry Hum Dev       Date:  2018-04

3.  Comparing diagnostic classification of neurobehavioral disorder associated with prenatal alcohol exposure with the Canadian fetal alcohol spectrum disorder guidelines: a cohort study.

Authors:  James L Sanders; Rebecca E Hudson Breen; Nicole Netelenbos
Journal:  CMAJ Open       Date:  2017-02-24

4.  Are Low-to-Moderate Average Alcohol Consumption and Isolated Episodes of Binge Drinking in Early Pregnancy Associated with Facial Features Related to Fetal Alcohol Syndrome in 5-Year-Old Children?

Authors:  Ulrik Schiøler Kesmodel; Siv Steffen Nygaard; Erik Lykke Mortensen; Jacquelyn Bertrand; Clark H Denny; Alex Glidewell; Susan Astley Hemingway
Journal:  Alcohol Clin Exp Res       Date:  2019-05-24       Impact factor: 3.455

5.  Prefrontal cortical responses in children with prenatal alcohol-related neurodevelopmental impairment: A functional near-infrared spectroscopy study.

Authors:  Julie A Kable; Claire D Coles
Journal:  Clin Neurophysiol       Date:  2017-09-02       Impact factor: 3.708

Review 6.  Global Prevalence of Fetal Alcohol Spectrum Disorder Among Children and Youth: A Systematic Review and Meta-analysis.

Authors:  Shannon Lange; Charlotte Probst; Gerrit Gmel; Jürgen Rehm; Larry Burd; Svetlana Popova
Journal:  JAMA Pediatr       Date:  2017-10-01       Impact factor: 16.193

7.  Response to Astley's Letter to the Editor.

Authors:  Claire D Coles; Amanda R Gailey; Jennifer G Mulle; Julie A Kable; Mary Ellen Lynch; Kenneth Lyons Jones
Journal:  Alcohol Clin Exp Res       Date:  2016-11-26       Impact factor: 3.455

Review 8.  Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.

Authors:  Jeffrey R Wozniak; Edward P Riley; Michael E Charness
Journal:  Lancet Neurol       Date:  2019-05-31       Impact factor: 44.182

9.  Neurodevelopmental Outcomes Associated with Prefrontal Cortical Deoxygenation in Children with Fetal Alcohol Spectrum Disorders.

Authors:  Julie A Kable; Claire D Coles; Sarah N Mattson
Journal:  Dev Neuropsychol       Date:  2020-01-08       Impact factor: 2.253

10.  The Standardization of Diagnostic Criteria for Fetal Alcohol Spectrum Disorder (FASD): Implications for Research, Clinical Practice and Population Health.

Authors:  Jasmine M Brown; Roger Bland; Egon Jonsson; Andrew J Greenshaw
Journal:  Can J Psychiatry       Date:  2018-05-22       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.